Rxivist logo

Genome-wide molecular effects of the neuropsychiatric 16p11 CNVs in an iPSC-to-iN neuronal model

By Thomas R. Ward, Xianglong Zhang, Louis C. Leung, Bo Zhou, Kristin Muench, Julien G. Roth, Arineh Khechaduri, Melanie J. Plastini, Carol Charlton, Reenal Pattni, Steve Ho, Marcus Ho, Yiling Huang, Joachim F. Hallmayer, Phillippe Mourrain, Theo D. Palmer, Alexander E. Urban

Posted 10 Feb 2020
bioRxiv DOI: 10.1101/2020.02.09.940965

Copy number variants (CNVs), either deletions or duplications, at the 16p11.2 locus in the human genome are known to increase the risk for autism spectrum disorders (ASD), schizophrenia, and for several other developmental conditions. Here, we investigate the global effects on gene expression and DNA methylation using a 16p11.2 CNV patient-derived induced pluripotent stem cell (iPSC) to induced neuron (iN) cell model system. This approach revealed genome-wide and cell-type specific alterations to both gene expression and DNA methylation patterns and also yielded specific leads on genes potentially contributing to some of the known 16p11.2 patient phenotypes. PCSK9 is identified as a possible contributing factor to the symptoms seen in carriers of the 16p11.2 CNVs. The protocadherin (PCDH) gene family is found to have altered DNA methylation patterns in the CNV patient samples. The iPSC lines used for this study are available through a repository as a resource for research into the molecular etiology of the clinical phenotypes of 16p11.2 CNVs and into that of neuropsychiatric and neurodevelopmental disorders in general.

Download data

  • Downloaded 376 times
  • Download rankings, all-time:
    • Site-wide: 79,594
    • In genetics: 3,510
  • Year to date:
    • Site-wide: 90,960
  • Since beginning of last month:
    • Site-wide: 117,239

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide